|Videos|December 20, 2022
Interview with Anthony Carpanzano (AAPS 2022)
Author(s)Chris Spivey
Anthony Carpanzano, Director of R&D at JRS Pharma, discussed ongoing formulation challenges and trends.
KEY LEARNING OBJECTIVES
- Overcoming formulation challenges in converting liquids into solid dose,
- Turning soft gel into tablets, enhancing dissolution,
- Simplifying modified-release formulations
Related Content
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
BMS Bets on Flexible Capacity With $2.3B Texas Campus
4
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
5